Client maintains a portfolio of several MS products with varying routes of administration and unique patient journey challenges that look different by country:

  • Several products faced complex titration portfolio and patient lack of confidence in self-injection. Rural/remote patients were also unable to access F2F care due to mobility challenges
  • National payer required cumbersome genotyping before authorizing treatment, which slowed down product uptake
  • Patients required first dose observation and titration navigation


Connect patients with doctors throughout their treatment journey, improving compliance through monitoring and the generation of real-time insights, complemented by a team of registered nurses and automation to assist patient follow up and education

-Onboarding welcome
-Pre-screening and titration/initiation support
-Adherence solution
-Country-specific nurse support approach

-First dose observation support
-Injection training videos, incl. integration
– Pre-screening pathology for genotyping (2x lab integrations;1 bi-directional; 1 via SFTP)
– Home drug delivery, incl. virtual pharmacy integration


83-98% adherence rates across the MS drugs in PSP
74% faster time to treatment, shortened from ~6 weeks to 11-16 days
63 net promoter score
92% satisfaction rating